Compare Essex Property Trust, Inc. (ESS) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Essex Property Trust, Inc. vs Medpace Holdings Inc — how do they compare? Essex Property Trust, Inc. trades at $271.57 (market cap $17.26B), while Medpace Holdings Inc trades at $612.05 (market cap $16.82B). The key difference: Essex Property Trust, Inc. and Medpace Holdings Inc are close in size by market cap, and Essex Property Trust, Inc. pays a 3.86% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Essex Property Trust, Inc. for 111 Days and Medpace Holdings Inc for 14 Days on average.
| ESS | MEDP | |
|---|---|---|
Market Cap | $17.26B | $16.82B |
Volume | 454,464 | 223,093 |
Sector | Real Estate | Health |
52-Week High | $298.33 | $630.19 |
52-Week Low | $239.61 | $393.42 |
Typical Hold Time | 111 Days | 14 Days |
Enterprise Value | $23.86B | $16.44B |
Dividend Yield | 3.86% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ESS trades at $268.58, up 0.2% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed quarterly earnings, missing in Q4 2025 and Q2 2026 but beating in Q1 2026, with revenue reaching $1.89 billion in 2025. Analyst consensus is a Buy with a $303.41 price target, though the stock faces headwinds from high valuation multiples and legal uncertainties recently resolved.
The outlook for ESS is cautiously optimistic, supported by strong operational efficiency and raised full-year guidance, but risks include elevated debt levels and sensitivity to real estate market cycles. Investment appeal hinges on execution of growth strategies amid economic fluctuations.
Medpace (MEDP) trades at $602.70, down 0.26% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent CEO stock sales and mixed institutional activity create near-term uncertainty, though analyst consensus remains positive with a $620.44 price target. The company is scheduled to report Q3 2026 results on October 21, 2026.
MEDP presents a compelling growth story with strong financial metrics, though elevated valuations (P/E 35.41) and insider selling warrant caution. Upside potential exists if Q3 earnings meet expectations, while failure to maintain growth momentum could pressure the stock. The current price near pivot point ($599) suggests balanced risk-reward ahead of earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Essex Property Trust, Inc.
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
